Medtronic PLC
Ownership
Ownership Structure
Who owns Medtronic PLC (MDT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 89.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.91 | 114,020,787 | +0.7 | 06/30/2026 |
| Vanguard Capital Management, LLC | 6.55 | 83,816,735 | +0.6 | 06/30/2026 |
| State Street Corp | 4.95 | 63,399,315 | +2.7 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 2.66 | 34,059,967 | +1.8 | 06/30/2026 |
| Geode Capital Management, LLC | 2.36 | 30,192,015 | +5.1 | 06/30/2026 |
| JPMorgan Chase & Co | 2.17 | 27,784,471 | -45.5 | 06/30/2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 2.15 | 27,567,966 | +174.5 | 06/30/2026 |
| Bank of America Corp | 1.67 | 21,322,401 | -18.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.17 | 40,621,279 | -0.4 | 09/30/2026 |
| Vanguard 500 Index Investor | 2.63 | 33,616,526 | -1.4 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Martha Geoffrey | Chairman and CEO | 277,866 | 26,814,069 $ | Oct 15, 2026 | direct |
| Marinaro Michael | EVP, Pres MedSurg and Americas | 105,916 | 10,220,894 $ | Oct 15, 2026 | direct |
| Pieton Thierry | EVP & Chief Financial Officer | 49,645 | 4,790,743 $ | Aug 3, 2026 | direct |
| Kiil Harry Skip | EVP & President Cardiovascular | 42,186 | 4,070,949 $ | Sep 16, 2026 | direct |
| Walter Matthew R. | SVP, Chief HR Officer | 39,928 | 3,853,052 $ | Aug 3, 2026 | direct |
| Thompson Kweli | EVP & President, Neuroscience | 35,390 | 3,415,135 $ | Aug 3, 2026 | direct |
| Quinn Michelle | EVP, GC and Secretary | 26,721 | 2,578,577 $ | Aug 3, 2026 | direct |
| Blomquist Denise L. | Chief Accounting Officer | 16,398 | 1,582,407 $ | Sep 15, 2026 | direct |
| Lofton Kevin E | Director | 9,977 | 962,781 $ | Oct 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Lofton Kevin E | Director | Other | 182 | – | – |
| Oct 15, 2026 | Medtronic plc | 10% Owner | Other | 252,813,348 | – | – |
| Oct 15, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Sell | 10,420 | 96.00 | 1,000,320 |
| Oct 15, 2026 | Martha Geoffrey | Chairman and CEO | Sell | 50,000 | 95.00 | 4,750,000 |
| Sep 16, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell | 1,483 | 93.65 | 138,883 |
| Sep 15, 2026 | Blomquist Denise L. | Chief Accounting Officer | Other | 600 | 0.00 | – |
| Aug 20, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Other | 1,084 | 92.30 | 100,053 |
| Aug 3, 2026 | Thompson Kweli | EVP & President, Neuroscience | Other | 6,923 | 0.00 | – |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | Other | 2,337 | 0.00 | – |
| Aug 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | Other | 11,537 | 0.00 | – |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Other | 5,769 | 0.00 | – |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Other | 46,147 | 0.00 | – |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Other | 10,960 | 0.00 | – |
| Aug 3, 2026 | Quinn Michelle | EVP, GC and Secretary | Other | 6,346 | 0.00 | – |
| Aug 3, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Other | 9,230 | 0.00 | – |
| Aug 3, 2026 | Martha Geoffrey | Chairman and CEO | Other | 41,533 | 0.00 | – |
| Jul 31, 2026 | Thompson Kweli | EVP & President, Neuroscience | Other | 1,739 | 85.39 | 148,493 |
| Jul 31, 2026 | Blomquist Denise L. | Chief Accounting Officer | Other | 212 | 85.39 | 18,103 |
| Jul 31, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Other | 1,675 | 85.39 | 143,028 |
| Jul 31, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Other | 3,356 | 85.39 | 286,569 |
| Jul 31, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Other | 3,074 | 85.39 | 262,489 |
| Jul 31, 2026 | Martha Geoffrey | Chairman and CEO | Other | 15,810 | 85.39 | 1,350,016 |
| Jul 28, 2026 | Quinn Michelle | EVP, GC and Secretary | Other | 2,069 | 86.88 | 179,755 |
| Jul 8, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Sell | 3,102 | 83.15 | 257,931 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.